Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter StudyEur Urol 2021 Aug 13;[EPub Ahead of Print], P Cheung, S Patel, SA North, A Sahgal, W Chu, H Soliman, B Ahmad, E Winquist, T Niazi, F Patenaude, G Lim, DYC Heng, A Dubey, P Czaykowski, RKS Wong, A Swaminath, SC Morgan, R Mangat, S Keshavarzi, GA Bjarnason
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.